Correlation Between Blueprint Medicines and Nurix Therapeutics

Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Nurix Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Nurix Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Blueprint Medicines Corp and Nurix Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Nurix Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Nurix Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Nurix Therapeutics.

Diversification Opportunities for Blueprint Medicines and Nurix Therapeutics

-0.14

Correlation Coefficient

Blueprint Medicines  Nurix Therapeutics

Good diversification

The 3 months correlation between Blueprint and Nurix is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Nurix Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nurix Therapeutics and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Nurix Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nurix Therapeutics has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Nurix Therapeutics go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Nurix Therapeutics

Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.7 times more return on investment than Nurix Therapeutics. However, Blueprint Medicines Corp is 1.42 times less risky than Nurix Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Nurix Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  4,671  in Blueprint Medicines Corp on October 21, 2024 and sell it today you would earn a total of  6,334  from holding Blueprint Medicines Corp or generate 135.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Blueprint Medicines Corp  vs.  Nurix Therapeutics

Blueprint Medicines Corp

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Blueprint Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Nurix Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Blueprint Medicines and Nurix Therapeutics

The main advantage of trading using opposite Blueprint Medicines and Nurix Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Nurix Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nurix Therapeutics will offset losses from the drop in Nurix Therapeutics' long position.

The idea behind Blueprint Medicines Corp and Nurix Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.